New insider activity at GE Healthcare Technologies Inc ( (GEHC) ) has taken place on May 1, 2026.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
GE Healthcare Technologies Inc. saw a notable insider move as Chief Financial Officer James Saccaro purchased 3,310 shares of the company’s stock in a transaction valued at $200,552. This insider buy may signal confidence from the company’s top financial executive in GE Healthcare’s current valuation and future prospects, and it adds a meaningful personal stake tied directly to shareholder outcomes.
Recent Updates on GEHC stock
GE HealthCare shares reacted to its Q1 report, where solid revenue, record backlog and strong Pharma Diagnostics and Imaging growth were overshadowed by weaker margins and a trimmed earnings outlook. Analysts lowered price targets mainly because rising input costs, tariffs, a supplier recall, China softness and dilution from the Intelerad deal are pressuring EPS and pushing most margin recovery benefits into 2026 and beyond.
Spark’s Take on GEHC Stock
According to Spark, TipRanks’ AI Analyst, GEHC is a Neutral.
The score is held back primarily by weak technicals and recent TTM softness in profitability and free cash flow alongside moderate leverage. Offsetting factors include a reasonable valuation and an earnings outlook that maintains revenue growth guidance and demand visibility (record backlog), though near-term margins and EPS face notable cost and tariff headwinds.
To see Spark’s full report on GEHC stock, click here.
More about GE Healthcare Technologies Inc
YTD Price Performance: -25.76%
Average Trading Volume: 4,024,461
Technical Sentiment Signal: Sell
Current Market Cap: $27.68B